Form 4: Avanos Medical Executive John Hurley Reports Stock Transactions Following Vesting of Restricted Share Units
SEC Form 4 Filing
John Hurley, Principal Accounting Officer of Avanos Medical, reports disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On March 6, 2025, John Hurley, Principal Accounting Officer of Avanos Medical, Inc., disposed of 141 shares of common stock at a price of $15.3 to cover tax obligations related to the vesting of time-based restricted share units (TRSUs) awarded on March 6, 2023.
- Additionally, Hurley disposed of 212 shares of common stock at the same price ($15.3) to cover tax obligations related to the vesting of TRSUs awarded on March 6, 2024.
- Following these transactions, Hurley directly owns 9,748 shares of Avanos Medical, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of award of 400 time-based restricted share units (TRSUs) which vested on March 6, 2025. |
| 03/06/2024 | Date of award of 603 time-based restricted share units (TRSUs) which vested on March 6, 2025. |
| 03/06/2025 | Date of transaction: Disposition of shares to cover tax obligations upon vesting of TRSUs. |
| 03/10/2025 | Date of signature of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.